Your gifts make it possible to
OUTSMART CANCER

At the Cancer Research Society, we recognize that it is our privilege to be the recipients of generous gifts from our supporters.Your donations are why we’re able to fund the best cancer research in the country, and it’s because of you that we continue to find ways to outsmart cancer and save lives.

 

As such, we make the following pledge to you:

 

  • Your gifts will be used for the sole purpose of supporting our mission: funding research on all types of cancer to help prevent, detect, and treat this disease.
  • We will strive to keep our cost of fundraising as low as possible while delivering the greatest impact.
  • Information about your donation will be handled with respect and with confidentiality to the extent provided by law.
  • You can be assured that our methods of fundraising are constantly reviewed, ethically-based, and minimize cost while maximizing impact.
  • You will receive acknowledgment and recognition in a timely manner.
  • If you have questions, comments, or feedback you can expect prompt, transparent, truthful, and forthright answers.

Your personal point of contact is:

Melanie Duhamel
Senior Donor Relations Agent
info@src-crs.ca
Toll free (English): 1 888 766 2262
Toll free (French): 1 866 343 2262

circle

Cancer research breakthroughs,
Thanks to YOU!

Dr. Rebecca Auer is investigating how two common drugs can be used in an uncommon way to provide innovative cancer care.

You make cancer research breakthroughs like this happen with your unwavering support.

Although surgery is a very effective means of removing solid tumours in cancer patients, it also suppresses the immune system. This means remaining cancer cells are sometimes able to metastasize and spread to surrounding organs following surgery.

Dr. Auer’s cancer research study treated mouse models with a combination of a common erectile dysfunction drug (Viagra) and inactivated influenza vaccine (Agriflu) in conjunction with surgery. Just 11 metastases occurred in mice who underwent both surgery and combination flu vaccine/erectile dysfunction drug therapy, compared to 129 metastases allowing cancer to spread in those treated only through surgery.

This marked improvement has significant implications for cancer research and cancer care.

Dr. Auer’s initial study was supported by operating grants from the Cancer Research Society between 2013 and 2017. Today, she is leading the first clinical trial examining the use of erectile dysfunction drugs and the flu vaccine in cancer care.

Dr. Auer’s progress could not have happened without donors like you placing your trust in the Cancer Research Society.

This discovery holds significant potential for the growing field of immunotherapy in cancer research – and it’s thanks in large part to supporters like you.